Search Results 881-890 of 17164 for treatment resistant depression
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...
... treatment refractory disease, intolerance, or refusal of the therapy; t(4;14) confirmed by standard of care FISH testing. Measurable disease, including at ...
The purpose of this study is to evaluate the effectiveness and safety of tazemetostat in combination with R2 in subjects with Relapsed/Refractory Follicular ...
The purpose of this study is to evaluate the effectiveness, safety and drug/body interactions of EDO-S101 in patients with relapsed or resistant hematologic ...
Happiness. In: The Practitioner's Guide to Anger Management: Customizable Interventions, Treatments, and Tools for Clients With Problem Anger. Kindle edition.
Sara McLaughlin, M.D., Surgical Oncologist, Department of Surgery: The goal is the more targeted things that we can give you, the more things that are ...
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers.
These include chemotherapy, hormone therapy, radiation, surgery, targeted therapy and immunotherapy. As newer cancer treatments become available, these might be ...
This clinical care center coordinates care across neurology ... New Mayo Clinic tool exposes hidden cancer DNA changes that may drive treatment resistance.
Medication Adherence, Depression, and Quality of Life in Renal Transplant Candidates J of Clin Psychol in Medical Settings. 2022; 29(1):168-184. Petrik M ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.